People living with type 1 diabetes may be able to manage, treat and potentially avoid kidney decline in the future, with the assistance of a simple blood test developed here in WA.
Proteomics International Laboratories (Proteomics International) has developed a test that looks at biomarkers in the blood to accurately predict the onset of chronic kidney disease (CKD) and future kidney decline in patients with type 2 diabetes, up to four years in advance.
It has now been tested in patients with type 1 diabetes for the first time, with promising results.
Proteomics International Managing Director Dr Richard Lipscombe, formerly from UWA, said researchers looked at the effectiveness of the test in more than 90 people with type 1 diabetes from the Fremantle Diabetes Study Phase II.
Read the whole article here
